Private Health Insurance classification of MBS items 1 October 2022
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
The ‘Private Health Insurance classification of MBS items 1 October 2022’ is derived from MBS XML Data file’XML-20221001-MBS’ released on 28 September 2022, and includes an amendment to pathology item 72814 to include testing of tumour material from a patient diagnosed with recurrent or metastatic squamous cell carcinoma of the oral cavity, pharynx or larynx. The file also includes ten new temporary pathology items (69506, 69507, 69508, 69509, 69510, 69511, 69512, 69513, 69514, and 69515) for pathology laboratory testing for SARS-CoV-2 (COVID-19) and other respiratory pathogens.
Further information on changes to the MBS1 October 2022, including fact sheets and quick reference guides is available at MBS Online.
PHI Spreadsheets reflect the assignment of MBS items by clinical category and procedure type set out in PHI rules, which will be accessible on the Federal Register of Legislation. Formal notification will be provided by Private Health Insurance Circular, and on the Federal Register of Legislation following the finalisation of regulatory approval processes.
We only update PHI Spreadsheets when MBS item changes result in changes to PHI clinical categorisations and procedure type classifications. Not all MBS XML Data File releases result in PHI Spreadsheet updates.
Receive notification of updates to PHI Spreadsheets, and other PHI information, by emailing PHI@health.gov.au requesting subscription to the email newsletter.
For older versions of this publication, review the Private health insurance clinical category and procedure type collection, or visit the National Library's web archive.